Co-Treatments of Edible Curcumin from Turmeric Rhizomes and Chemotherapeutic Drugs on Cytotoxicity and FLT3 Protein Expression in Leukemic Stem Cells

Co-Treatments of Edible Curcumin from Turmeric Rhizomes and Chemotherapeutic Drugs on Cytotoxicity and FLT3 Protein Expression in Leukemic Stem Cells

This study aims to enhance efficacy and reduce toxicity of the combination treatment of a drug and curcumin (Cur) on leukemic stem cell and leukemic cell lines, including KG-1a and KG-1 (FLT3<sup>+</sup> LSCs), EoL-1 (FLT3<sup>+</sup> LCs), and U937 (FLT3<sup>−</sup&...

Full description

Bibliographic Details
Main Authors: Fah Chueahongthong, Singkome Tima, Sawitree Chiampanichayakul, Cory Berkland, Songyot Anuchapreeda
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Molecules
Subjects:
leukemia
leukemic stem cell
FLT-3
chemotherapeutic drug
curcumin
co-treatment
Online Access:https://www.mdpi.com/1420-3049/26/19/5785

Internet

https://www.mdpi.com/1420-3049/26/19/5785

Similar Items